Analysis: Moderna Vaccine Found Safe, Effective Ahead of Key FDA Review

About This Source - Bloomberg QuickTake: Now

Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.

It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Recent from Bloomberg QuickTake: Now:

  • “Kill The Bill” Protests Continue In Cities Across England
  • Libya Begins Public Vaccination Campaign
  • Myanmar Junta Pardons More Than 23,000 Prisoners
  • Bloomberg Quicktake: Now published this video item, entitled “Analysis: Moderna Vaccine Found Safe, Effective Ahead of Key FDA Review” – below is their description.

    Moderna Inc.’s vaccine is safe and effective for preventing Covid-19, U.S. regulators said, clearing the way for a second shot to quickly gain emergency authorization and add to the country’s sprawling immunization effort.

    The Food and Drug Administration’s staff said in a report on Tuesday that the experimental vaccine is 94.1% effective at preventing symptomatic Covid-19, confirming earlier results released by the company.

    The report was posted online ahead of a meeting Thursday of agency advisers who will vote whether to recommend authorization before a final FDA decision. The agency doesn’t have to follow the advice of the independent vaccine experts, though it often agrees with its advisory panels. Last week, the FDA authorized a similar vaccine from Pfizer Inc. and BioNTech SE after an advisory panel voted 17-4, with one abstention, to support its authorization.

    The FDA got a much deeper look at Moderna’s clinical-trial data than the numbers previously released to the public by the company. Notably, the agency was able to review the shot’s effectiveness across a broad range of racial, ethnic and age groups, and look at evidence of how well the shot worked for people with pre-existing medical conditions that make them more vulnerable to severe Covid-19.

    The agency found the shot was similarly effective across racial and ethnic groups and those with underlying medical conditions. It was 86.4% effective in people age 65 and over, according to the report, and 95.6% effective in those 18 to 65.

    Both the Moderna vaccine and the Pfizer vaccine are based on messenger RNA technology that hasn’t been previously used in inoculations. Additionally, both are two-dose vaccines, meaning once people receive an initial shot they will need to return to their care providers weeks later for an additional injection.

    Between Pfizer and Moderna, Operation Warp Speed officials have said 20 million people in the U.S. are expected to get their first shots by year-end.

    Covid-19 cases and hospitalizations are rising across the country, increasing pressure to get the pathogen under control. While health officials are hopeful that the immunization push will begin to slow a pandemic that has killed more than 300,000 Americans, it’s not yet known what effect the vaccines have on transmission of the disease.

    Pfizer and BioNTech’s vaccine was cleared first in the U.K. where there were a few reports of serious reactions that led regulators there to advise against anyone with a history of significant allergies getting the shot. The FDA did not take such a step, but told facilities where the vaccine would be administered to have medication on hand to treat possible allergic reactions, including a severe form called anaphylaxis.

    Moderna’s vaccine isn’t yet approved in any other countries and hasn’t yet been used on anyone outside of a clinical trial.

    Once the U.S. grants authorization, advisers to the Centers for Disease Control and Prevention must meet, as they did last week on Pfizer’s vaccine, to give Moderna’s shot the green light and provide offer specific recommendations for use and monitoring. Moderna’s vaccine will be distributed to sites around the country where health-care workers and residents of long-term care facilities, such as nursing homes, are expected to get the earliest doses.

    Pfizer and BioNTech’s first vaccines were sent to more than 600 sites around the country. The shot must be kept extremely cold and requires special freezers to transport, while Moderna’s can be kept in more traditional cold storage.

    Bloomberg Quicktake: Now YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: BioNTech

    BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

    5 Recent Items: BioNTech

  • Can Covid vaccines be mixed? | ITV News
  • U.S. Recommends ‘Pause’ for Johnson & Johnson Vaccine Over Blood Clot Reports
  • J&J Vaccine: Six Cases of Rare Blood Clot Disorder Found in U.S.
  • Lockdown, not vaccines behind drop in UK COVID-19 deaths: Boris Johnson
  • South African Covid variant may evade the Pfizer vaccine, according to Israeli study
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Can Covid vaccines be mixed? | ITV News
  • New Delhi faces hospital beds shortage
  • The West Block: April 18, 2021 | Canada struggles to cope with 3rd wave of COVID-19
  • Ontario police, activists push back against expanded enforcement
  • Prince Philip’s funeral: Royal Family farewells a husband, father, grandfather | 9 News Australia
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • Dr. Fauci, Rep. Jordan Clash Over What It Will Take to End the Covid Pandemic
  • Pfizer to deliver 8M more vaccines, as Moderna announces shortfall
  • Ontario reports record-breaking 4,736 new COVID-19 cases, total count surpasses 400,000 | FULL
  • Vaccine Watch: How far away are COVID-19 booster shots?
  • Thousands of COVID-19 vaccine appointments cancelled in Ontario due to supply shortage
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • Can Covid vaccines be mixed? | ITV News
  • Dr. Fauci, Rep. Jordan Clash Over What It Will Take to End the Covid Pandemic
  • Fmr. FDA commissioner says it was ‘prudent’ to pause J&J vaccine
  • Trudeau says new agreement with Pfizer to double COVID-19 vaccine doses in coming months | LIVE
  • Pfizer to deliver 8M more vaccines, as Moderna announces shortfall
  • Leave a Comment